Apricus Biosciences (APRI) Tops Q1 EPS by 4c

Apricus Biosciences (NASDAQ: APRI) reported Q1 EPS of ($0.05), $0.04 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $626 thousand versus the consensus estimate of $920 thousand.

For earnings history and earnings-related data on Apricus Biosciences (APRI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c